A Novel AAV8 Vector for Microdystrophin Gene Therapy of Duchenne Muscular Dystrophy: Preclinical Studies in the Mdx Mouse

被引：0
|
作者：
Kim, SunJung [1 ]
Buss, Nicholas [1 ]
Patel, Hiren [1 ]
Yang, Lin [1 ]
Elliott, Kirk [1 ]
Qiao, Chunping [1 ]
Liu, Ye [1 ]
Fiscella, Michele [1 ]
Danos, Olivier [1 ]
机构：
[1] REGENXBIO Inc, Rockville, MD USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
614
引用
收藏
页码：297 / 298
页数：2
相关论文
共 50 条
  • [41] Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
    Duan, Dongsheng
    MOLECULAR THERAPY, 2018, 26 (10) : 2337 - 2356
  • [42] Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene
    B M Koppanati
    J Li
    D P Reay
    B Wang
    M Daood
    H Zheng
    X Xiao
    J F Watchko
    P R Clemens
    Gene Therapy, 2010, 17 : 1355 - 1362
  • [43] An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice
    Gillis, JM
    ACTA NEUROLOGICA BELGICA, 2000, 100 (03) : 146 - 150
  • [44] Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene
    Koppanati, B. M.
    Li, J.
    Reay, D. P.
    Wang, B.
    Daood, M.
    Zheng, H.
    Xiao, X.
    Watchko, J. F.
    Clemens, P. R.
    GENE THERAPY, 2010, 17 (11) : 1355 - 1362
  • [45] Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy
    Bourg, Nathalie
    Vu Hong, Ai
    Lostal, William
    Jaber, Abbass
    Guerchet, Nicolas
    Tanniou, Guillaume
    Bordier, Fanny
    Bertil-Froidevaux, Emilie
    Georger, Christophe
    Daniele, Nathalie
    Richard, Isabelle
    Israeli, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [46] The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy
    David W. Hammers
    Cora C. Hart
    Michael K. Matheny
    Lillian A. Wright
    Megan Armellini
    Elisabeth R. Barton
    H. Lee Sweeney
    Scientific Reports, 10
  • [47] GNT0004, Genethon's AAV8 vector-delivered microdystrophin gene therapy of Duchenne muscular dystrophy, first data of the phase I/II part of the GNT-016-MDYF all-in-one clinical trial in ambulant boys
    Laugel, V.
    De Lucia, S.
    Davion, J.
    Daniele, N.
    Cao, F.
    Sanz, M.
    Buscara, L.
    Blaie, S.
    Thibaut, L.
    Sagot, M.
    Riviere, A.
    Creoff, E.
    Lelait, M.
    Valent, A.
    Perret, G.
    Braun, S.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [48] The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy
    Hammers, David W.
    Hart, Cora C.
    Matheny, Michael K.
    Wright, Lillian A.
    Armellini, Megan
    Barton, Elisabeth R.
    Sweeney, H. Lee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [49] Development of gene therapy for Duchenne muscular dystrophy using systemic delivery of AAV vectors
    Chamberlain, J. S.
    Gregorevic, P.
    Schultz, B.
    Odom, G.
    Finn, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S124 - S124
  • [50] AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial
    Mendell, Jerry R.
    Muntoni, Francesco
    Mcdonald, Craig M.
    Mercuri, Eugenio M.
    Ciafaloni, Emma
    Komaki, Hirofumi
    Leon-Astudillo, Carmen
    Nascimento, Andres
    Proud, Crystal
    Schara-Schmidt, Ulrike
    Veerapandiyan, Aravindhan
    Zaidman, Craig M.
    Guridi, Maitea
    Murphy, Alexander P.
    Reid, Carol
    Wandel, Christoph
    Asher, Damon R.
    Darton, Eddie
    Mason, Stefanie
    Potter, Rachael A.
    Singh, Teji
    Zhang, Wenfei
    Fontoura, Paulo
    Elkins, Jacob S.
    Rodino-Klapac, Louise R.
    NATURE MEDICINE, 2025, 31 (01) : 332 - 341
12345